High- and Moderate-Intensity Inspiratory Muscle Training on Diaphragm Ultrasound Parameters, Cognition, and Mental Health
Comparison of High- and Moderate-Intensity Inspiratory Muscle Training on Diaphragm Ultrasound Parameters, Cognition, and Mental Health in Young Adults With Low Muscle Mass Index: A Randomized Controlled Trial
Low skeletal muscle mass during young adulthood may impair diaphragm function, cognition, sleep, and psychological well-being. Inspiratory muscle training (IMT) has been shown to improve respiratory muscle performance; however, it remains unclear whether different IMT intensities produce differential effects on diaphragm morphology and function, cognition, sleep, anxiety, and health-related quality of life.
The purpose of this randomized controlled trial is to compare the effects of high-intensity inspiratory muscle training (HI-IMT), moderate-intensity inspiratory muscle training (MI-IMT), and sham inspiratory muscle training in young adults with low skeletal muscle mass.
A total of 69 participants with low skeletal muscle mass will be randomly assigned to one of three groups: (1) HI-IMT, (2) MI-IMT, or (3) sham IMT. Participants will complete a supervised 6-week intervention consisting of five training sessions per week.
Participants allocated to the HI-IMT group will perform inspiratory muscle training at approximately 80% of maximal inspiratory pressure (MIP), whereas those in the MI-IMT group will train at approximately 50-60% of MIP. The sham group will perform low-intensity inspiratory muscle training at approximately 15% of MIP. Training intensity will be adjusted throughout the intervention according to repeated MIP assessments.
Outcome assessments will be performed before and after the intervention. Primary outcomes will include diaphragm thickness, diaphragm thickening fraction, and diaphragm excursion assessed using ultrasonography. Secondary outcomes will include cognitive function assessed using the Montreal Cognitive Assessment (MoCA), sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI), daytime sleepiness assessed using the Epworth Sleepiness Scale (ESS), insomnia severity assessed using the Insomnia Severity Index (ISI), anxiety assessed using the State-Trait Anxiety Inventory (STAI), and health-related quality of life assessed using the Short Form-36 Health Survey (SF-36).
The primary hypothesis is that both HI-IMT and MI-IMT will improve diaphragm morphology and function, cognition, sleep, anxiety, and health-related quality of life compared with sham IMT. It is further hypothesized that HI-IMT will produce greater improvements than MI-IMT because of the higher inspiratory training intensity.
調査の概要
詳細な説明
Low skeletal muscle mass during young adulthood has become an increasingly recognized public health concern because it is associated with reduced physical performance, impaired metabolic health, and an increased risk of developing sarcopenia later in life. In addition to peripheral skeletal muscles, reduced muscle mass may affect diaphragm structure and function, potentially contributing to impaired respiratory mechanics as well as alterations in cognition, sleep, psychological well-being, and health-related quality of life. Although inspiratory muscle training (IMT) has been widely used to improve inspiratory muscle performance, the influence of different IMT intensities on diaphragm morphology and multidimensional health outcomes has not been fully established.
This randomized, sham-controlled clinical trial is designed to compare the effects of high-intensity inspiratory muscle training (HI-IMT), moderate-intensity inspiratory muscle training (MI-IMT), and sham inspiratory muscle training in young adults with low skeletal muscle mass. The primary objective is to determine whether training intensity influences changes in diaphragm structure and function assessed by ultrasonography. Secondary objectives are to evaluate the effects of different IMT intensities on cognitive function, sleep quality, daytime sleepiness, insomnia severity, anxiety, and health-related quality of life.
Participants aged 18-25 years with low skeletal muscle mass will be randomly assigned to one of three parallel groups using age- and sex-stratified block randomization. Participants allocated to the HI-IMT group will perform inspiratory muscle training at approximately 80% of maximal inspiratory pressure (MIP), whereas participants in the MI-IMT group will train at approximately 50-60% of MIP. Participants in the sham group will perform inspiratory muscle training using minimal resistance (approximately 15% of MIP). The intervention will last 6 weeks, with five training sessions per week. One session each week will be supervised by a physiotherapist, and the remaining sessions will be completed at home with regular monitoring.
Outcome assessments will be performed before and after the intervention. Primary outcome measures will include diaphragm thickness, diaphragm thickening fraction, and diaphragm excursion assessed using ultrasonography. Secondary outcome measures will include body composition, cognitive function assessed using the Montreal Cognitive Assessment (MoCA), sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI), daytime sleepiness assessed using the Epworth Sleepiness Scale (ESS), insomnia severity assessed using the Insomnia Severity Index (ISI), anxiety assessed using the State-Trait Anxiety Inventory (STAI) and the Generalized Anxiety Disorder-7 (GAD-7), and health-related quality of life assessed using the Short Form-36 Health Survey (SF-36).
The study is designed to evaluate whether different inspiratory muscle training intensities are associated with differences in diaphragm morphology and function, cognitive function, sleep, anxiety, and health-related quality of life in young adults with low skeletal muscle mass.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Tunceli、トルコ（Türkiye）
- Munzur University Faculty of Health Sciences
-
-
参加基準
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Young adults aged 18 to 25 years.
- Low skeletal muscle mass defined as a skeletal muscle mass index (SMI) < 8.87 kg/m² for men and < 6.42 kg/m² for women.
- Clinically stable and able to safely participate in inspiratory muscle training.
- Willing and able to provide written informed consent.
- Able to comply with the study procedures and complete all assessments.
Exclusion Criteria:
- Presence of cardiovascular, neurological, orthopedic, psychiatric, respiratory, or other systemic diseases that could influence study outcomes.
- History of surgery that could affect participation or outcome assessments.
- Cognitive, psychological, or mental conditions that could interfere with participation or completion of the assessments.
- Inability or unwillingness to complete the intervention protocol or follow-up assessments.
- Any contraindication to inspiratory muscle training as determined by the investigators.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：High-Intensity Inspiratory Muscle Training (HI-IMT) Group
Participants assigned to this group completed a 6-week high-intensity inspiratory muscle training program using a POWERbreathe Classic Light Resistance device.
Training was performed five days per week, including one supervised session and four home-based sessions.
The initial training load was set at approximately 80% of the predicted maximal inspiratory pressure (MIP) and was progressively adjusted weekly to maintain the target training intensity.
|
Participants performed a 6-week high-intensity inspiratory muscle training program using a threshold-loading inspiratory muscle trainer (POWERbreathe Classic Light Resistance).
Training was conducted five days per week, consisting of one supervised session and four home-based sessions.
The initial training intensity was set at approximately 80% of the predicted maximal inspiratory pressure (MIP) and was progressively adjusted weekly to maintain the target training intensity according to perceived exertion.
|
|
実験的：Moderate-Intensity Inspiratory Muscle Training (MI-IMT) Group
Participants assigned to this group completed a 6-week moderate-intensity inspiratory muscle training program using a POWERbreathe Classic Light Resistance device.
Training was performed five days per week, including one supervised session and four home-based sessions.
The initial training load was set at 50-60% of the predicted maximal inspiratory pressure (MIP) and was progressively adjusted weekly to maintain the prescribed training intensity.
|
Participants performed a 6-week moderate-intensity inspiratory muscle training program using a threshold-loading inspiratory muscle trainer (POWERbreathe Classic Light Resistance).
Training was conducted five days per week, consisting of one supervised session and four home-based sessions.
The initial training intensity was set at 50-60% of the predicted maximal inspiratory pressure (MIP) and was progressively adjusted weekly to maintain the prescribed training intensity.
|
|
偽コンパレータ：Sham Training Group
Participants assigned to this group completed a 6-week sham inspiratory muscle training program using the same device and training schedule.
The resistance was maintained at 15% of maximal inspiratory pressure (MIP) throughout the intervention to provide minimal inspiratory loading without an intended training effect.
|
Participants completed a 6-week sham inspiratory muscle training program using the same threshold-loading inspiratory muscle trainer.
The intervention followed the same schedule as the active groups (five sessions per week, including one supervised and four home-based sessions), while the resistance was maintained at 15% of maximal inspiratory pressure throughout the study to provide minimal inspiratory loading without an intended training effect.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Diaphragm Thickness Measured by Ultrasonography
時間枠：Baseline and Week 6
|
Diaphragm thickness will be assessed using B-mode ultrasonography at functional residual capacity (FRC) and total lung capacity (TLC).
The primary outcome is the change in diaphragm thickness from baseline to completion of the 6-week intervention.
Measurements will be performed by a blinded radiologist using a standardized ultrasound protocol.
|
Baseline and Week 6
|
|
Change in Diaphragm Thickening Fraction
時間枠：Baseline and Week 6
|
Diaphragm thickening fraction measured by ultrasonography.
The outcome is the change from baseline to Week 6.
|
Baseline and Week 6
|
|
Change in Diaphragm Excursion
時間枠：Baseline and Week 6
|
Diaphragm excursion (mobility) measured by ultrasonography.
The outcome is the change from baseline to Week 6.
|
Baseline and Week 6
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Montreal Cognitive Assessment (MoCA) Score
時間枠：Baseline and Week 6
|
Cognitive function assessed using the Montreal Cognitive Assessment (MoCA).
The Montreal Cognitive Assessment is a 30-point cognitive screening instrument with total scores ranging from 0 to 30.
Higher scores indicate better cognitive function.
The outcome measure is the change in total score from baseline to Week 6.
|
Baseline and Week 6
|
|
Change in Pittsburgh Sleep Quality Index (PSQI) Score
時間枠：Baseline and Week 6
|
Sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI).
The Pittsburgh Sleep Quality Index is a 21-point questionnaire with total scores ranging from 0 to 21.
Higher scores indicate poorer sleep quality.
The outcome measure is the change in total score from baseline to Week 6.
|
Baseline and Week 6
|
|
Change in Epworth Sleepiness Scale (ESS) Score
時間枠：Baseline and Week 6
|
Daytime sleepiness assessed using the Epworth Sleepiness Scale (ESS).
The Epworth Sleepiness Scale is a 24-point questionnaire with total scores ranging from 0 to 24.
Higher scores indicate greater daytime sleepiness.
The outcome measure is the change in total score from baseline to Week 6.
|
Baseline and Week 6
|
|
Change in Insomnia Severity Index (ISI) Score
時間枠：Baseline and Week 6
|
Insomnia severity assessed using the Insomnia Severity Index (ISI).
The Insomnia Severity Index is a 28-point questionnaire with total scores ranging from 0 to 28.
Higher scores indicate greater insomnia severity.
The outcome measure is the change in total score from baseline to Week 6.
|
Baseline and Week 6
|
|
Change in State Anxiety Inventory (STAI-State) Score
時間枠：Baseline and Week 6
|
State anxiety assessed using the State-Trait Anxiety Inventory-State (STAI-State).
The State-Trait Anxiety Inventory-State is a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater state anxiety.
The outcome measure is the change in total score from baseline to Week 6.
|
Baseline and Week 6
|
|
Change in Trait Anxiety Inventory (STAI-Trait) Score
時間枠：Baseline and Week 6
|
Trait anxiety assessed using the State-Trait Anxiety Inventory-Trait (STAI-Trait).
The State-Trait Anxiety Inventory-Trait is a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater trait anxiety.
The outcome measure is the change in total score from baseline to Week 6.
|
Baseline and Week 6
|
|
Change in Generalized Anxiety Disorder-7 (GAD-7) Score
時間枠：Baseline and Week 6
|
Generalized anxiety symptoms assessed using the Generalized Anxiety Disorder 7-item Scale (GAD-7).
The Generalized Anxiety Disorder 7-item Scale is a 7-item questionnaire with total scores ranging from 0 to 21.
Higher scores indicate greater anxiety symptom severity.
The outcome measure is the change in total score from baseline to Week 6.
|
Baseline and Week 6
|
|
Change in Short Form-36 (SF-36) Total Score
時間枠：Baseline and Week 6
|
Health-related quality of life assessed using the 36-Item Short Form Health Survey (SF-36).
The 36-Item Short Form Health Survey generates a total score ranging from 0 to 100, with higher scores indicating better health-related quality of life.
The outcome measure is the change in total score from baseline to Week 6.
|
Baseline and Week 6
|
協力者と研究者
スポンサー
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 2025/16-2
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。